How it works
How Much Does Immunotherapy for lung cancer Cost in Turkey in AUD?
Immunotherapy for lung cancer in Turkey typically costs from AUD $12,000 to AUD $19,500. Total expenses depend on the specific drug brand, the number of cycles required, and diagnostic biomarker testing. Packages often include oncologist consultations, airport transfers, and interpreter services.
- Checkpoint inhibitor brand: Prices vary by 20–30% between common drugs like Keytruda or Opdivo.
- Biomarker profiling: PD-L1 testing and PET-CT scans add to initial diagnostic costs.
- Hospital location: Treatment in Istanbul typically costs 15–20% more than in regional cities like Antalya.
- Facility accreditation: JCI-accredited centres usually sit at the higher end of the pricing scale.
Bookimed Expert Insight: Turkish oncology centres provide high-value care by following international NCCN and ESMO guidelines. Anadolu Medical Center is even affiliated with Johns Hopkins Hospital, offering American-standard protocols at Turkish prices. Specialists like Professor Yesim Yildirim have published over 80 scientific works, ensuring your treatment uses the latest global research. Choosing a multi-disciplinary hospital ensures you have access to advanced technologies like MR-LINAC if your protocol requires integrated radiotherapy.
Best Immunotherapy for lung cancer Clinics in Turkey for Australians: 20 Verified Options and AUD Prices
Hisar Hospital Intercontinental
Mustafa Solak







Memorial Şişli Hospital
Serkan Keskin







Memorial Ataşehir Hospital
Kamil Yalçın Polat


Immunotherapy for lung cancer Overview in Turkey
- Immunotherapy - from AUD $3,756This therapy boosts the body"s natural defenses to fight diseases like cancer, bringing less side effects.
- Bacillus Calmette-Guérin (BCG) therapy - from AUD $10,518This therapy, employing a TB vaccine, aids in bladder cancer treatment, through direct insertion into the bladder.
- Immunotherapy with Keytruda (Pembolizumab) - from AUD $4,207The therapy is a treatment enhancing the body"s immune system to fight cancer, using a drug highly targeted and effective.
- Immunotherapy for prostate cancer - from AUD $12,020This therapy boosts the body"s immune system to fight against prostate cancer, offering a targeted, typically well-tolerated treatment.
- Immunotherapy for lung cancer - from AUD $12,020This therapy boosts your body"s natural defenses to fight lung cancer, using substances made by the body itself.
- Immunotherapy for breast cancer - from AUD $12,020This therapy boosts your immune system to fight and eradicate breast cancer cells effectively.
- Immunotherapy for kidney cancer - from AUD $12,020This therapy boosts the body"s natural defenses, often prolonging life in kidney cancer patients.
- Sarcoma Immunotherapy - from AUD $13,373This therapy boosts the body"s immune system to fight cancerous tumors, offering promising, targeted treatment for sarcoma.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Trusted Doctors for Australian Patients
View all Doctors
Bulent Karagoz
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
- Authored over 40 research publications focusing on tumor biology and immunology.
- Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
- Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
- Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Serdar Turhal
Dr. Eda Tanrikulu ranks among Turkey's top oncologists, specializing in immunotherapy for lung cancer at Anadolu Medical Center.
- Specialized in medical oncology at Marmara University – ranked 3rd in Turkey
- Led international clinical studies on advanced cancer treatments
- Former head of medical oncology at Haydarpaşa Numune Research Hospital

Prof. Sezer Sağlam
Prof. Sezer Sağlam specializes in immunotherapy for lung cancer at Gayrettepe Florence Nightingale Hospital, one of Istanbul's leading oncology centers.
- Professor of Medical Oncology with extensive experience in gastrointestinal oncology
- Fellowship-trained at Istanbul University Medical Faculty
- Member of ESMO, ASCO, and European Neuroendocrine Tumour Society
- Works at American Cancer Center within Florence Nightingale Hospital

Serkan Keskin
Dr. Serkan Keskin is a medical oncologist at Memorial Şişli Hospital in Istanbul. He ranked first in Turkey in the 2012 Medical Oncology Proficiency Exam. Dr. Keskin treats over 25 types of cancer, including breast, lung, and stomach cancers. He works at a JCI-accredited facility recognized for excellence in oncology.
- Secured second place in Turkey in the 2009 Minor Specialty Certificate Examination.
- Maintains membership in both the American Society of Clinical Oncology (ASCO) and ESMO.
- Uses chemotherapy, targeted therapy, and immunotherapy to treat complex tumors.
- Winner of the Best Poster Award at the 19th National Cancer Congress.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about Immunotherapy for lung cancer in Turkey
What are the side effects and risks of immunotherapy for lung cancer in Turkey?
Immunotherapy for lung cancer in Turkey commonly causes immune-related side effects affecting skin, digestion and hormones. Pneumonitis occurs in about 3% of patients, with liver inflammation in roughly 20%. Rare risks include heart and brain inflammation, usually managed by specialised care.
- Immune-related adverse effects: rash, itching, diarrhoea, colitis, thyroid issues
- Pneumonitis risk: lung inflammation causing cough and chest pain in 3%
- Liver and organ inflammation risk: hepatitis and others, about 20%
- General symptoms: fatigue and severe tiredness common after treatment
- Rare serious risks: myocarditis, encephalitis and nerve inflammations
Bookimed Expert Insight: Clinics like Anadolu Medical Center with Joint Commission International (JCI) accreditation use close monitoring to manage side effects effectively. Experienced oncologists such as Prof Bulent Karagoz provide immunotherapy with familiar drugs like Keytruda and Opdivo, improving safety. Coordination including interpreters and personalised schedules eases treatment for international patients, especially Australians.
Patient Consensus: First doses are often well tolerated with mild effects. Respiratory symptoms like deep cough and neurological signs need prompt attention. Patients find it helpful when immunotherapy sessions are well scheduled every 2–3 weeks alongside local GP advice. Turkish clinics are known for professional staff and attentive care.
What types of immunotherapy are available for lung cancer treatment in Turkey?
Turkey offers a range of immunotherapy treatments for lung cancer, including immune checkpoint inhibitors like pembrolizumab (Keytruda) and nivolumab (Opdivo). Options include bispecific antibodies, LAG-3 antibodies, and mRNA vaccines combined with PD-1 inhibitors, available in leading centres such as Anadolu Medical Center.
- Immune checkpoint inhibitors: Keytruda and Opdivo used for NSCLC and SCLC.
- Bispecific antibodies: Target PD-L1 and 4-1BB, such as BNT327 and Acasunlimab.
- Combination therapies: mRNA vaccines paired with PD-1 inhibitors like cemiplimab.
- Clinical trials: Access to next-gen immunotherapies and antibody-drug conjugates.
- Testing standards: PD-L1 and genetic panels to guide treatment choice.
Bookimed Expert Insight: Turkey leads in clinical trials for lung cancer immunotherapy, offering patients access to novel bispecific antibodies and mRNA vaccines not widely available elsewhere. Top clinics like Anadolu Medical Center serve thousands yearly and combine proven drugs with research, offering personalised treatment options that adapt to disease progression.
Patient Consensus: Patients in Turkey appreciate quick access to immunotherapy and report longer disease stability. Many note comprehensive testing at hospitals helps tailor treatment. Australians find the clinical trial options and new antibody combinations promising during their treatment stays.
How long do patients typically receive immunotherapy for lung cancer in Turkey?
Immunotherapy for lung cancer in Turkey typically lasts between 12 months and two years. Some patients, especially those with stable disease, may receive lifelong treatment. Clinics offer systemic immunotherapy with drugs like Keytruda and Opdivo, personalised by oncologists based on cancer type and response.
- Standard duration: Systemic immunotherapy usually continues up to 24 months or until disease progression.
- Adjuvant treatment: Immunotherapy after surgery typically lasts around 12 months.
- Special protocols: Some centres provide 3-month intratumoral immunotherapy with Pulsed Electrical Field Ablation.
- Follow-up: Treatment length depends on patient tolerance and cancer stability.
- Biomarker testing: Critical for determining personalised immunotherapy suitability and duration.
Bookimed Expert Insight: Turkish top clinics like Anadolu Medical Center personalise immunotherapy duration widely. Lifelong treatment during stable disease is common, while some patients fit shorter 3-month intratumoral plans, showing Turkey’s diverse care approaches for Australians seeking tailored lung cancer treatment.
Patient Consensus: Patients in Turkey often highlight the clear communication about immunotherapy length and personalised care. Many appreciate updated biomarker testing, with treatment plans adapting to progress, ensuring efficient lung cancer management.
How can Australian patients access lung cancer immunotherapy treatment in Turkey?
Australian patients access lung cancer immunotherapy in Turkey through specialised hospitals like Anadolu Medical Center. These centres offer treatments including Keytruda and personalised plans after thorough oncologist reviews. International patient services coordinate travel, translation, and remote follow-up for smooth treatment and care continuity.
- Specialised hospitals: Anadolu Medical Center and Memorial Şişli Hospital lead lung cancer immunotherapy.
- Immunotherapy options: Keytruda and targeted therapies are available for lung cancer treatment.
- Patient services: Coordinators assist with travel, interpreters, and medical documentation.
- Oncologist review: Free medical record evaluation and personalised treatment planning are offered.
- Follow-up care: Remote consultations maintain care connection with Australian doctors post-treatment.
Bookimed Expert Insight: Anadolu Medical Center stands out with 65,000 patients yearly and extensive international patient coordination. Their oncologists, like Prof. Bulent Karagoz, have strong global ties, ensuring advanced immunotherapy access. Australian patients benefit most by using official hospital programs to avoid costly private intermediaries.
Patient Consensus: Patients value direct contact with Turkish accredited hospitals to avoid scams. They highlight well-coordinated travel and treatment experiences, plus ongoing support through remote follow-ups. Immunotherapy drugs like Keytruda are readily available, ensuring quality care in Turkey.



























